OSUWMC--James Cancer Hospital
Locations
Transplant Summary
Overview
The BMT Program at The James offers a 36-bed acute care unit dedicated to providing outstanding patient care. The program was initiated in 1984 and is FACT and AABB accredited. We transplant many different diseases and have innovative research (including novel clinical trials) and technology available.This center has been performing allogeneic transplants since 1984 and has been an NMDP transplant center since July 1989.
Attending physicians
Adult - Evandro Bezerra, Jonathan Brammer, Hannah Choe, Marcos de Lima, Nathan Denlinger, Nicole Grieselhuber, Meixiao Long, Sam Penza, Gabriela Sanchez-Petitto, Polina Shindiapina, Sumithira Vasu, Sarah Wall, Jason WangTransplants performed
Marrow/PBSC and double cordCord blood transplants
Adult onlyOther programs and services
CAR-T protocols.Patient survival information for this center
This center's actual 1-year survival results are similar to the expected rate for this center*.The survival information we have for this center includes ONLY:- Patients who had their FIRST ALLOGENEIC transplant (cells from a related or unrelated donor/cord blood) during 2020, 2021, 2022 and
- Who had their transplant at a U.S. transplant center, and
- Who had follow-up information provided by the transplant center for analysis
For this center, we have survival information for 250 patients.The actual 1-year survival of these patients is 79.2%.Compared to similar patients transplanted at all centers in the U.S., we expect that the 1-year survival for patients at this center to be in a range between 70% and 80.2%.For help with understanding these statistics, please see Understanding Transplant Outcomes.For overall survival for all patients transplanted with a specific disease, please see U.S. Patient Survival report (Opens in a new tab) at bloodcell.transplant.hrsa.gov.* The expected survival rate for a transplant center can be below, similar to, or above the range listed. This is based on comparing patient survival at all centers that treated patients with similar diseases.
The survival rate cannot tell how you will do with your transplant. Talk to your doctor to understand your prognosis or the likely course of your disease.
Total adult transplants
481
Transplants reported by the centers (from January 1, 2022 to December 31, 2023)
Marrow PBSC Cord blood Total AllogeneicRelated donorMarrow9PBSC50Cord blood0Total59Unrelated donorMarrow5PBSC124Cord blood0Total129Total allogeneicMarrow14PBSC174Cord blood0Total188AutologousMarrowBoth marrow & PBSC 293PBSC—Cord blood—Total293Total combinedMarrowBoth marrow & PBSC 481PBSC—Cord blood0Total481All Diseases
Number of transplants by age reported from January 1, 2022 to December 31st, 2023(includes marrow, PBSC and cord blood)
0-18 19-44 45-64 65+ Total Related 0-18019-441845-642665+14Total58Unrelated 0-18019-442645-646865+35Total129Autologous 0-18019-443945-6414365+111Total293Total 0-18019-448345-6423765+160Total480Treatments may be similar for diseases within a group. It might be helpful to look at centers that have done transplants for a specific disease and centers that have done transplants for any corresponding broad disease categories.
Centers are not required to report autologous transplants so the numbers might be incomplete.
More information about transplants can be found:
- U.S. Transplant Data by Center (Opens in a new tab) report at blood cell.transplant.hrsa.gov
- List of diseases
Transplant center resources
NMDP patient navigators
Patient navigators can answer your questions about choosing a transplant center and provide support and education to help you throughout your transplant journey.
- Inside the United States: 1 (888) 999-6743
- Outside the United States: 1 (763) 406-3410. (Long distance or international charges may apply.)
Email: patientinfo@nmdp.org
More resources
- Choosing a transplant center
- Preparing for transplant
- Learn about transplant outcomes and treatment decisions (Opens in a new tab)
- Support and resources (including non-English materials)
- U.S. Transplant Data by Center (Opens in a new tab) at blood cell.transplant.hrsa.gov
OSU - The James Cancer Hospital
B315 Starling Loving Hall, 320 W 10 th Ave Columbus, OH 43210 Phone:614-293-0666 Physician Referrals:614-293-3153 Staff
Program Director:Annie TranceProgram Coordinator:Denise SchimmingMedical Specialties in Program
Complementary and alternative medicine, gynecology, nephrology, palliative care, Physical medicine and rehab, psychiatry/psychology, pulmonology.Medical Services Offered
Fertility counseling, reproductive health, nutrition/dietetics, occupational therapy, pain management, physical therapy and rehabilitation, sexual health, social services.Telemedicine services are available.Patient Eligibility
Adults- Allogeneic transplant recipients
- Adults: 100 days after transplant.
- Adults (over age 18)
- Will provide care to adult patients who underwent transplant as a child
- Does accept patients who were transplanted at another hospital